Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic

Arch Med Res. 2022 Jul;53(5):543-544. doi: 10.1016/j.arcmed.2022.05.004. Epub 2022 May 25.

Authors

Elena Noris-García¹, Maria DE Los Angeles Robinson-Agramonte², Carlos-Alberto Gonçalves³

Affiliations

¹ Instituto de Nefrología, Departamento de Inmunología, Havana, Cuba.
² Universidad de Ciencias Médicas de La Habana and Centro Internacional de Restauración Neurológica, Departamento de Neuroinmunología, Havana, Cuba.
³ Universidade Federal do Rio Grande do Sul, Programas de Pós-Graduação em Bioquímica e Neurociências, Porto Alegre, Brazil. Electronic address: casg@ufrgs.br.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
COVID-19*
Humans
Lupus Erythematosus, Systemic* / diagnosis
Pandemics
S100 Calcium Binding Protein beta Subunit
SARS-CoV-2

Substances

Biomarkers
S100 Calcium Binding Protein beta Subunit
S100B protein, human